ALC-0315 is an ionizable cationic lipid (pKa 6.09) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA, siRNA, and plasmid DNA in vitro and in vivo.
LNPs containing ALC-0315 and encapsulating siRNA targeting Factor VII mRNA decrease Factor VII mRNA levels in hepatocytes in mice. Administration of severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA in ALC-0315-containing LNPs induces the production of IgG that binds to the SARS-CoV-2 receptor-binding domain (RBD) in rhesus macaques, with a boost in antigen-specific IgG geometric mean titers (GMT) seven and 14 days after a second dose. LNPs containing ALC-0315 and encapsulating ovalbumin mRNA reduce tumor volume in an ovalbumin-expressing B16/F10 murine melanoma model. Formulations containing ALC-0315 have been used in the development of LNPs for the delivery of mRNA-based vaccines.
Shipping & Storage Information
Storage: -20°C
Shipping: Wet ice in continental US; may vary elsewhere
Stability: ≥ 2 year
NOTE: Research Use Only
top of page
$450.00Price
No Reviews YetShare your thoughts.
Be the first to leave a review.
bottom of page